Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie’s disease using two different electromagnetic lithotripters - Takeaways - MDSpire

Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie’s disease using two different electromagnetic lithotripters

  • By

  • Jens J. Rassweiler

  • W. Scheitlin

  • A. S. Goezen

  • F. Radecke

  • March 7, 2024

  • 0 min

Share

  • 1

    Peyronie’s disease is characterized by penile fibrosis leading to deformity, pain, and shortening, affecting 3-20% of men, especially those with diabetes.

  • 2

    Extracorporeal shock wave therapy (ESWT) was introduced for chronic Peyronie’s disease, showing pain reduction but mixed results on plaque treatment.

  • 3

    High-energy ESWT was applied to 110 patients over 20 years using two electromagnetic lithotripters, with 85 patients providing sufficient long-term data.

  • 4

    Patients treated with high-energy ESWT had a median disease duration of 14 months, with many having previously undergone other treatments without success.

  • 5

    The study aimed to evaluate the effectiveness of high-energy ESWT in managing Peyronie’s disease, comparing results from two different lithotripters.

Original Source(s)

Long-term experiences with high-energy shock wave therapy in the management chronic phase Peyronie’s disease using two different electromagnetic lithotripters

  • by Jens J. Rassweiler, W. Scheitlin, A. S. Goezen, F. Radecke

  • March 7, 2024

Related Content

Assessing peri-operative antibiotic administration practices amongst urologic surgeons performing holmium laser enucleation of the prostate worldwide

Retrospective, single center evaluation of transperineal prostate biopsy omitting antibiotic prophylaxis and omitting periinterventional screening for bacteriuria

SMART Stone Multidisciplinary Team (MDT) and patient care: recommendations for the adult high-risk kidney stone patient pathway